Alexander Scheffold

Title: Alexander Scheffold: Innovator in Immunotherapy

Introduction

Alexander Scheffold is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on regulatory T cells.

Latest Patents

Scheffold holds a patent for a "Regulatory T cell expressing a chimeric antigen receptor." This invention provides a regulatory T (Treg) cell that expresses an antigen chimeric receptor. The receptor comprises at least one antigen binding domain, a transmembrane domain, and a cytoplasmic signaling domain. The cytoplasmic signaling domain includes at least one primary cytoplasmic signaling domain and the co-stimulatory signaling domain of CD137. This Treg cell specifically binds to an antigen expressed on the surface of a target cell, enhancing the potential for targeted immunotherapy.

Career Highlights

Throughout his career, Scheffold has worked with notable organizations, including Miltenyi Biotec B.V. & Co. KG and Charité-Universitätsmedizin Berlin. His work in these institutions has allowed him to advance his research and contribute to the development of innovative therapies.

Collaborations

He has collaborated with esteemed colleagues such as Anna Nowak and Dominik Lock, further enriching his research endeavors and expanding the impact of his work in the field of immunotherapy.

Conclusion

Alexander Scheffold's contributions to the field of immunotherapy through his innovative patent and collaborations highlight his role as a key figure in advancing medical science. His work continues to inspire future developments in targeted therapies.